Search results
CorMedix Inc. (NASDAQ:CRMD) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoCorMedix Inc. (NASDAQ:CRMD) Q4 2023 Earnings Call Transcript March 12, 2024 CorMedix Inc. misses on...
Insider Buying: Cormedix Inc CEO Joseph Todisco Acquires 10,000 Shares
GuruFocus.com via Yahoo Finance· 9 months agoOn September 8, 2023, Joseph Todisco, the CEO of Cormedix Inc (NASDAQ:CRMD), purchased 10,000 shares...
CorMedix Inc. (CRMD) Q1 2024 Earnings: Net Loss Widens, Misses Analyst Forecasts
GuruFocus.com via Yahoo Finance· 4 weeks agoNet Loss: Reported a net loss of $14.5 million for Q1 2024, which is below above the estimated net...
Breakeven On The Horizon For CorMedix Inc. (NASDAQ:CRMD)
Simply Wall St. via Yahoo Finance· 2 months agoCorMedix Inc. (NASDAQ:CRMD) is possibly approaching a major achievement in its business, so we would...
CorMedix (NASDAQ:CRMD) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. via Yahoo Finance· 6 months agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
CorMedix Slapped With Second FDA Rejection For DefenCath
Benzinga via Yahoo Finance· 2 years agoCorMedix Inc (NASDAQ: CRMD) received a second Complete Response Letter (CRL) from the FDA for...
CorMedix Third Quarter 2022 Earnings: US$0.17 loss per share (vs US$0.23 loss in 3Q 2021)
Simply Wall St. via Yahoo Finance· 2 years agoCorMedix (NASDAQ:CRMD) Third Quarter 2022 ResultsKey Financial Results Net loss: US$6.85m (loss...
Q2 2023 CorMedix Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 months agoParticipants Elizabeth Masson-Hurlburt; Executive VP and Head of Clinical & Medical Affairs; CorMedix Inc. Erin Mistry; Executive VP & Chief Commercial Officer; CorMedix Inc. Joseph Todisco; ...
We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely
Simply Wall St. via Yahoo Finance· 2 years agoJust because a business does not make any money, does not mean that the stock will go down. For...
